News
Pharmalittle: We’re reading about Sarepta conceding to the FDA, the U.S. transplant system, and more
Sarepta Therapeutics reversed course and agreed to halt all shipments of Elevidys, its gene therapy for Duchenne muscular ...
Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.
Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy ...
The FDA will request Sarepta Therapeutics stop all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, ...
A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to the company's gene therapies ...
Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
Mast is the foundation body in a bladeless wind turbine, its interaction with fluid (air or water) generates vibrations that in turn harvest usable electricity. Care must be taken while designing the ...
Army Corps Col. Brandon L. Bowman said the agency needs various analyses to determine "the likelihood and magnitude of ...
Jason Kelce has been a cornerstone of the Philadelphia community ever since he was drafted in the sixth round out of Cincinnati back in 2011. He went on to become not only one of the best centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results